13:07:47 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-11-07 Kvartalsrapport 2024-Q3
2024-08-22 Kvartalsrapport 2024-Q2
2024-05-02 Kvartalsrapport 2024-Q1
2024-03-14 X-dag ordinarie utdelning GN 0.00 DKK
2024-03-13 Årsstämma
2024-02-08 Bokslutskommuniké 2023
2023-11-10 Kvartalsrapport 2023-Q3
2023-08-17 Kvartalsrapport 2023-Q2
2023-04-27 Kvartalsrapport 2023-Q1
2023-03-16 X-dag ordinarie utdelning GN 0.00 DKK
2023-03-15 Årsstämma
2023-02-09 Bokslutskommuniké 2022
2022-11-11 Kvartalsrapport 2022-Q3
2022-08-18 Kvartalsrapport 2022-Q2
2022-05-05 Kvartalsrapport 2022-Q1
2022-03-10 X-dag ordinarie utdelning GN 1.55 DKK
2022-03-09 Årsstämma
2022-02-10 Bokslutskommuniké 2021
2021-10-29 Kvartalsrapport 2021-Q3
2021-08-19 Kvartalsrapport 2021-Q2
2021-05-06 Kvartalsrapport 2021-Q1
2021-03-18 X-dag ordinarie utdelning GN 1.45 DKK
2021-03-17 Årsstämma
2021-02-11 Bokslutskommuniké 2020
2020-11-11 Kvartalsrapport 2020-Q3
2020-08-19 Kvartalsrapport 2020-Q2
2020-04-29 Kvartalsrapport 2020-Q1
2020-03-12 X-dag ordinarie utdelning GN 1.45 DKK
2020-03-11 Årsstämma
2020-02-05 Bokslutskommuniké 2019
2019-11-07 Kvartalsrapport 2019-Q3
2019-08-22 Kvartalsrapport 2019-Q2
2019-05-01 Kvartalsrapport 2019-Q1
2019-03-22 X-dag ordinarie utdelning GN 1.35 DKK
2019-03-21 Årsstämma
2018-11-15 Kvartalsrapport 2018-Q3
2018-08-22 Kvartalsrapport 2018-Q2
2018-05-02 Kvartalsrapport 2018-Q1
2018-03-14 X-dag ordinarie utdelning GN 1.25 DKK
2018-03-13 Årsstämma
2018-02-07 Bokslutskommuniké 2017
2017-11-02 Kvartalsrapport 2017-Q3
2017-08-17 Kvartalsrapport 2017-Q2
2017-05-04 Kvartalsrapport 2017-Q1
2017-03-15 X-dag ordinarie utdelning GN 1.15 DKK
2017-03-14 Årsstämma
2017-02-09 Bokslutskommuniké 2016
2016-11-03 Kvartalsrapport 2016-Q3
2016-08-11 Kvartalsrapport 2016-Q2
2016-05-04 Kvartalsrapport 2016-Q1
2016-03-11 X-dag ordinarie utdelning GN 0.99 DKK
2016-03-10 Årsstämma
2016-02-12 Bokslutskommuniké 2015
2015-10-30 Kvartalsrapport 2015-Q3
2015-08-13 Kvartalsrapport 2015-Q2
2015-04-29 Kvartalsrapport 2015-Q1
2015-03-20 X-dag ordinarie utdelning GN 0.90 DKK
2015-03-19 Årsstämma
2015-02-18 Bokslutskommuniké 2014
2014-11-14 Kvartalsrapport 2014-Q3
2014-08-14 Kvartalsrapport 2014-Q2
2014-05-02 Kvartalsrapport 2014-Q1
2014-03-24 X-dag ordinarie utdelning GN 0.84 DKK
2014-03-21 Årsstämma
2014-02-14 Bokslutskommuniké 2013
2013-11-15 Kvartalsrapport 2013-Q3
2013-08-14 Kvartalsrapport 2013-Q2
2013-05-03 Kvartalsrapport 2013-Q1
2013-03-22 X-dag ordinarie utdelning GN 0.49 DKK
2013-03-21 Årsstämma
2013-02-21 Bokslutskommuniké 2012
2012-11-15 Kvartalsrapport 2012-Q3
2012-08-09 Kvartalsrapport 2012-Q2
2012-05-03 Kvartalsrapport 2012-Q1
2012-03-23 X-dag ordinarie utdelning GN 0.27 DKK
2012-03-22 Årsstämma
2012-02-23 Bokslutskommuniké 2011
2011-11-10 Kvartalsrapport 2011-Q3
2011-08-11 Kvartalsrapport 2011-Q2
2011-05-05 Kvartalsrapport 2011-Q1
2011-03-28 X-dag ordinarie utdelning GN 0.19 DKK
2011-03-25 Årsstämma
2010-11-10 Kvartalsrapport 2010-Q3
2010-08-11 Kvartalsrapport 2010-Q2
2010-05-07 Kvartalsrapport 2010-Q1
2010-03-19 X-dag ordinarie utdelning GN 0.00 DKK
2009-03-24 X-dag ordinarie utdelning GN 0.00 DKK
2008-03-12 X-dag ordinarie utdelning GN 0.00 DKK
2007-03-22 X-dag ordinarie utdelning GN 0.00 DKK
2006-03-22 X-dag ordinarie utdelning GN 0.60 DKK
2005-03-15 X-dag ordinarie utdelning GN 0.60 DKK
2004-04-01 X-dag ordinarie utdelning GN 0.60 DKK

Beskrivning

LandDanmark
ListaLarge Cap Copenhagen
SektorHandel & varor
IndustriSällanköpsvaror
GN Store Nord är verksamt inom medicinteknik. Bolaget är specialiserat inom intelligenta ljudlösningar för hörapparater - och headset. Hörapparaterna är trådlösa och används vanligtvis hos personer med nedsatt hörsel men säljs även för privat bruk. Produkterna säljs under separata varumärken och inkluderar exempelvis ReSound och Jabra. Bolaget har anor tillbaka till 1869 och har sitt huvudkontor i Ballerup, Danmark.
2023-06-28 21:50:52

Continued execution of new capital plan to strengthen capital structure and drive growth 

Today, GN has signed an agreement to divest BelAudição, Unipessoal Lda (“BelAudição”) to MCH Private Equity. BelAudição is the owner of the leading retailer of hearing aid solutions in Portugal, AudiçãoActiva, with around 50 hearing aid stores and 2022 revenues of around EUR 35 million and topline growth of 24%.

MCH Private Equity is an independent private equity firm based on the Iberian Peninsula with a focus on investing in companies with high potential in attractive sectors. Their mission is to support mid-sized businesses in transformation processes, ranging from the transition of ownership in family-owned companies to the internationalization and development of organic and inorganic growth plans.

The transaction demonstrates GN Hearing’s commitment to its successful strategy of not owning retail and instead focus on being a key supplier to strong independent hearing aid dispensers. GN finalized the acquisition of BelAudição – a long-time GN Hearing customer – in 2022 to facilitate a generational transition. GN Hearing has, therefore, carefully considered potential buyers to back the next phase of BelAudição’s impressive growth journey while securing that GN Hearing remains a key supplier of hearing aids to the business.

Gitte Aabo, CEO of GN Hearing, says: “We are very pleased to have found a new strong owner for BelAudição, a high performing hearing care retailer with an impressive growth track-record. GN Hearing continues to be fully committed to BelAudição and hearing aid users across Portugal as a key supplier of leading hearing aid technology. Together with MCH Private Equity’s local presence and expertise, BelAudição now has strong backing to execute their ambitious growth plans to the benefit of all parties. Further, this divestment is also an important step in executing GN’s new capital plan to strengthen the capital structure and continue to drive growth and innovation.”

Andrés Peláez, Senior Partner at MCH, comments: "MCH's acquisition of BelAudição is a strategic step in our vision to invest in promising Spanish and Portuguese companies with growth potential. This acquisition strengthens MCH's position in the market and reaffirms our commitment to support the development of companies in key sectors.”

Alantra is serving as exclusive financial advisor to GN on the transaction. Vieira de Almeida (VdA) and Uría Menéndez-Proença de Carvalho (UMPC) are serving as legal counsels to GN and MCH respectively.

Key transaction highlights

The transaction is an important milestone in the newly announced capital plan to strengthen GN’s capital structure where proceeds from selected asset disposals amount to DKK 1-2 billion. The divestment of BelAudição will contribute DKK ~500 million of that target. The transaction is expected to close in Q3 2023 subject to MCH Private Equity completing financing and obtaining anti-trust clearance.

The divestment of BelAudição is not impacting the financial guidance of GN Hearing.

For further information, please contact:

Investor Relations
Anne Sofie Staunsbæk Veyhe +45 45 75 85 06
Rune Sandager +45 45 75 92 57


Media Relations
Steen Frentz Laursen +45 20 65 34 20

About GN 
GN brings people closer through our leading intelligent hearing, audio, video, and gaming solutions. Inspired by people and driven by innovation, we deliver technology that enhance the senses of hearing and sight. We help people with hearing loss overcome real-life challenges, improve communication and collaboration for businesses, and provide great experiences for audio and gaming enthusiasts.

GN was founded more than 150 years ago with a vision to connect the world. Today, inspired by our strong heritage, GN touches more lives than ever with our unique expertise and the broadest portfolio of products and services in our history – bringing people closer to what is important to them.

We market our solutions with the brands Jabra, ReSound, SteelSeries, Beltone, Interton, BlueParrott, Danavox, and FalCom in 100 countries. Founded in 1869, GN Group employs more than 7,500 people and is listed on Nasdaq Copenhagen (GN.CO).

Visit our homepage GN.com - and connect with us on LinkedIn, Facebook and Twitter

About MCH Private Equity
MCH is a private equity fund set up in 1998. The company manages more than 1.2 billion euros through different funds, being one of the leading companies in the Spanish market and one of the largest private and independent private equity groups in Spain. The funds focus their activity on acquiring significant stakes in companies of relevant size in the Iberian Peninsula, pioneers in their corresponding markets and managed by solid professional teams, with the aim of boosting their growth and internationalization.

MCH is currently investing its fifth fund, having complete operations in leading companies such as Molecor (development of molecular orientation technology applied to pressurized water channeling), Prosur (natural ingredients for the food industry) or Logalty (digital signature and electronic contracting), among others.